chr10-121517371-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000141.5(FGFR2):c.1032G>A(p.Ala344Ala) variant causes a synonymous change. The variant allele was found at a frequency of 0.00000205 in 1,461,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
FGFR2
NM_000141.5 synonymous
NM_000141.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.75
Genes affected
FGFR2 (HGNC:3689): (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-121517371-C-T is Pathogenic according to our data. Variant chr10-121517371-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 13268.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-121517371-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFR2 | NM_000141.5 | c.1032G>A | p.Ala344Ala | synonymous_variant | 8/18 | ENST00000358487.10 | NP_000132.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.1032G>A | p.Ala344Ala | synonymous_variant | 8/18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
FGFR2 | ENST00000613048.4 | c.765G>A | p.Ala255Ala | synonymous_variant | 7/17 | 5 | ENSP00000484154.1 | |||
FGFR2 | ENST00000478859.5 | c.348G>A | p.Ala116Ala | synonymous_variant | 7/17 | 1 | ENSP00000474011.1 | |||
FGFR2 | ENST00000457416.7 | c.1087+1311G>A | intron_variant | 1 | ENSP00000410294.2 | |||||
FGFR2 | ENST00000369056.5 | c.1087+1311G>A | intron_variant | 1 | ENSP00000358052.1 | |||||
FGFR2 | ENST00000369058.7 | c.1087+1311G>A | intron_variant | 1 | ENSP00000358054.3 | |||||
FGFR2 | ENST00000369061.8 | c.749-2052G>A | intron_variant | 1 | ENSP00000358057.4 | |||||
FGFR2 | ENST00000369059.5 | c.742+1311G>A | intron_variant | 5 | ENSP00000358055.1 | |||||
FGFR2 | ENST00000360144.7 | c.820+1311G>A | intron_variant | 2 | ENSP00000353262.3 | |||||
FGFR2 | ENST00000604236.5 | n.*79G>A | non_coding_transcript_exon_variant | 7/17 | 1 | ENSP00000474109.1 | ||||
FGFR2 | ENST00000604236.5 | n.*79G>A | 3_prime_UTR_variant | 7/17 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251454Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135904
GnomAD3 exomes
AF:
AC:
1
AN:
251454
Hom.:
AF XY:
AC XY:
1
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727234
GnomAD4 exome
AF:
AC:
3
AN:
1461870
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Crouzon syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Sep 17, 2016 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Baylor Genetics | Nov 18, 2018 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 15, 2005 | - - |
not provided Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2022 | Published functional studies demonstrate abnormal gene splicing (Del Gatto et al., 1995; Li et al., 1995); Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 7987400, 12400057, 15286168, 7773284, 16158432, 26841243, 25271085, 24127277, 30692697, 7558045, 11781872, 8957519) - |
FGFR2-related craniosynostosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This sequence change affects codon 344 of the FGFR2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the FGFR2 protein. RNA analysis indicates that this variant induces altered splicing and likely results in the loss of 17 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is present in population databases (rs121918491, gnomAD 0.0009%). This variant has been observed in individuals with clinical features of Crouzon syndrome (PMID: 7987400, 8957519, 16838304). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13268). Studies have shown that this variant results in the activation of a cryptic splice site in exon 8 (PMID: 7773284). For these reasons, this variant has been classified as Pathogenic. - |
FGFR2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | May 06, 2022 | PS3 PS4 PP1 - |
Pfeiffer syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Functional studies provide supporting evidence of the variant having a damaging effect on the gene or gene product (PMID:7773284). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID:16418739, 16838304, 24127277, 8957519). The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000013268). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Acrocephalosyndactyly type I;C0010273:Crouzon syndrome;C0024623:Gastric cancer;C0175699:Saethre-Chotzen syndrome;C0220658:Pfeiffer syndrome;C0265269:Levy-Hollister syndrome;C0795998:Jackson-Weiss syndrome;C1852406:Beare-Stevenson cutis gyrata syndrome;C1865070:Familial scaphocephaly syndrome, McGillivray type;C2936791:Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis;C3281247:Bent bone dysplasia syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 17, 2021 | - - |
Scaphocephaly and axenfeld-rieger anomaly Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 15, 2005 | - - |
Craniosynostosis, nonclassifiable autosomal dominant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 15, 2005 | - - |
Acrocephalosyndactyly type I;C0010273:Crouzon syndrome;C0038356:Neoplasm of stomach;C0175699:Saethre-Chotzen syndrome;C0220658:Pfeiffer syndrome;C0265269:Levy-Hollister syndrome;C0795998:Jackson-Weiss syndrome;C1852406:Beare-Stevenson cutis gyrata syndrome;C1865070:Familial scaphocephaly syndrome, McGillivray type;C2936791:Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis;C3281247:Bent bone dysplasia syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Craniosynostosis syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 20, 2015 | - - |
Acrocephalosyndactyly type I Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at